1 Day
Source:
التيار الوطني الحر
Source: التيار الوطني الحر
1 Dayالتيار الوطني الحر
Source: التيار الوطني الحر
1 DayReady to play
Ready to play
A study of more than 80,000 people with type 2 diabetes in Italy warned that stopping GLP-1 weight-loss injections was associated with nearly double the risk of heart attack, stroke, or death compared with continuing treatment. The findings estimated about four cases per 100 people per year among those who stopped treatment, compared with two among those who continued. However, the study was observational, so it cannot prove that stopping the injections caused the increased risk. Experts urged caution in interpreting the findings.
Notice: This Is an AI-Generated Summary
Comments (0)